Clinical Trial Update: Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program [Phase 3]

View source ↗

Summary

Phase 3 trial assessing semaglutide combined with an intensive lifestyle program for weight reduction in overweight or obese individuals has completed with post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Overweight, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2021-07-09